From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination

Vaccine. 2011 Mar 3;29(11):2149-58. doi: 10.1016/j.vaccine.2010.12.078. Epub 2011 Jan 6.

Abstract

Although studies have suggested that a patient's perceived cost-benefit of a medical intervention could affect his or her utilization of the intervention, the economic value of influenza vaccine from the patient's perspective remains unclear. Therefore, we developed a stochastic decision analytic computer model representing an adult's decision of whether to get vaccinated. Different scenarios explored the impact of the patient being insured versus uninsured, influenza attack rate, vaccine administration costs and vaccination time costs. Results indicated that the cost of avoiding influenza was fairly low (with one driver being required vaccination time). To encourage vaccination, decision makers may want to focus on ways to reduce this time, such as vaccinating at work, churches, or other normally frequented locations.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Computer Simulation
  • Cost-Benefit Analysis
  • Decision Making
  • Disease Outbreaks / economics
  • Disease Outbreaks / prevention & control*
  • Humans
  • Influenza A Virus, H1N1 Subtype
  • Influenza Vaccines / economics*
  • Influenza, Human / economics
  • Influenza, Human / prevention & control*
  • Middle Aged
  • Vaccination / economics*
  • Young Adult

Substances

  • Influenza Vaccines